Clinical trial
Efficacy and Safety of Carotegrast Methyl in Active Ulcerative Colitis: A Real-World Prospective Cohort Study
NCT06897150 is registered in ClinicalTrials.gov with Takayuki Yamamoto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Carotegrast Methyl in Active Ulcerative Colitis: A Real-World Prospective Cohort Study
- Lead sponsor
- Takayuki Yamamoto
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 1, 2022
- Completion date
- March 15, 2025
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis